Alerts will be sent to your verified email
Verify EmailGUFICBIO
|
Gufic Biosciences
|
Bliss GVS Pharma
|
Unichem Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
1.28 % | 2.7 % | 5.35 % |
|
Financials
|
|||
|
5 yr Average ROE
|
16.89 % | 6.83 % | 1.64 % |
|
5yr average Equity Multiplier
|
2.16 | 1.3 | 1.32 |
|
5yr Average Asset Turnover Ratio
|
0.75 | 0.62 | 0.47 |
|
5yr Avg Net Profit Margin
|
10.24 % | 8.7 % | -1.68 % |
|
Price to Book
|
4.57 | 2.62 | 1.07 |
|
P/E
|
57.61 | 24.16 | 8.82 |
|
5yr Avg Cash Conversion Cycle
|
-15.25 Days | 186.56 Days | 88.84 Days |
|
Inventory Days
|
71.73 Days | 54.35 Days | 151.32 Days |
|
Days Receivable
|
106.89 Days | 189.93 Days | 122.86 Days |
|
Days Payable
|
179.29 Days | 75.78 Days | 205.05 Days |
|
5yr Average Interest Coverage Ratio
|
8.9 | 14.68 | 2.41 |
|
5yr Avg ROCE
|
17.89 % | 13.27 % | 1.04 % |
|
5yr Avg Operating Profit Margin
|
18.12 % | 17.03 % | 5.43 % |
|
5 yr average Debt to Equity
|
0.67 | 0.11 | 0.11 |
|
5yr CAGR Net Profit
|
-2.66 % | 4.24 % | 32.0 % |
|
5yr Average Return on Assets
|
7.7 % | 5.31 % | -0.65 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.5 % | 35.36 % | 70.22 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.5 % | 0.32 % | 19.29 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.6 % | 0.0 | 2.38 % |
|
Gufic Biosciences
|
Bliss GVS Pharma
|
Unichem Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|